Eli Lilly stock slips again as April orforglipron decision and FDA GLP-1 ad crackdown loom
New York, March 3, 2026, 17:25 EST — After-hours Eli Lilly and Company wrapped up Tuesday’s session down roughly 1%, settling at $1,007.73. That followed a 3.23% drop the previous day.